Literature DB >> 2544673

Infection of rats with bovine leukaemia virus: establishment of a virus-producing rat cell line.

V Altanerova1, D Portetelle, R Kettmann, C Altaner.   

Abstract

Adult rats were infected with bovine leukaemia virus (BLV). Inoculated rats persistently produced antibodies directed against viral structural proteins. No major pathogenesis in infected rats was found during 2 years of observation. It was possible to recover the virus from rat spleen several months after infection. A cell line, R(BLV), was established from rat spleen; this contained integrated BLV provirus. R(BLV) cells kept for over 80 passages in vitro produced viral particles with the properties of BLV. Provirus reintegration and/or amplification occurred in R(BLV) cells. The cell line was found to be tumorigenic in rats, and the virus produced was immunogenic. R(BLV) cells represent the first described BLV-producing rat cell line. Proven persistent infection with BLV indirectly suggests that rats can serve as a reservoir of BLV in nature.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2544673     DOI: 10.1099/0022-1317-70-7-1929

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  13 in total

1.  The mouse homolog of the bovine leukemia virus receptor is closely related to the delta subunit of adaptor-related protein complex AP-3, not associated with the cell surface.

Authors:  T Suzuki; H Ikeda
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

2.  Polyclonal bovine sera but not virus-neutralizing monoclonal antibodies block bovine leukemia virus (BLV) gp51 binding to recombinant BLV receptor BLVRcp1.

Authors:  O Orlik; J Ban; J Hlavaty; C Altaner; R Kettmann; D Portetelle; G A Splitter
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

3.  Bovine leukemia virus structural gene vectors are immunogenic and lack pathogenicity in a rabbit model.

Authors:  L Kucerova; V Altanerova; C Altaner; K Boris-Lawrie
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

4.  Long-term infection with retroviral structural gene vector provides protection against bovine leukemia virus disease in rabbits.

Authors:  Veronika Altanerova; Dana Holicova; Lucia Kucerova; Cestmir Altaner; Michael D Lairmore; Kathleen Boris-Lawrie
Journal:  Virology       Date:  2004-11-24       Impact factor: 3.616

5.  Isolation and characterization of a 2.3-kilobase-pair cDNA fragment encoding the binding domain of the bovine leukemia virus cell receptor.

Authors:  J Ban; D Portetelle; C Altaner; B Horion; D Milan; V Krchnak; A Burny; R Kettmann
Journal:  J Virol       Date:  1993-02       Impact factor: 5.103

6.  Whole genome sequencing of 51 breast cancers reveals that tumors are devoid of bovine leukemia virus DNA.

Authors:  Nicolas A Gillet; Luc Willems
Journal:  Retrovirology       Date:  2016-11-04       Impact factor: 4.602

Review 7.  Bovine Leukemia Virus Infection in Neonatal Calves. Risk Factors and Control Measures.

Authors:  Vanesa Ruiz; Natalia Gabriela Porta; Marina Lomónaco; Karina Trono; Irene Alvarez
Journal:  Front Vet Sci       Date:  2018-10-25

8.  Animal models on HTLV-1 and related viruses: what did we learn?

Authors:  Hiba El Hajj; Rihab Nasr; Youmna Kfoury; Zeina Dassouki; Roudaina Nasser; Ghada Kchour; Olivier Hermine; Hugues de Thé; Ali Bazarbachi
Journal:  Front Microbiol       Date:  2012-09-21       Impact factor: 5.640

Review 9.  Mechanisms of leukemogenesis induced by bovine leukemia virus: prospects for novel anti-retroviral therapies in human.

Authors:  Nicolas Gillet; Arnaud Florins; Mathieu Boxus; Catherine Burteau; Annamaria Nigro; Fabian Vandermeers; Hervé Balon; Amel-Baya Bouzar; Julien Defoiche; Arsène Burny; Michal Reichert; Richard Kettmann; Luc Willems
Journal:  Retrovirology       Date:  2007-03-16       Impact factor: 4.602

Review 10.  Mechanisms of pathogenesis induced by bovine leukemia virus as a model for human T-cell leukemia virus.

Authors:  Yoko Aida; Hironobu Murakami; Masahiko Takahashi; Shin-Nosuke Takeshima
Journal:  Front Microbiol       Date:  2013-11-08       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.